Your browser doesn't support javascript.
loading
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study.
Ehrlich, Marc; Hentschke, Christian; Sieder, Christian; Maier-Peuschel, Monika; Reuter, Uwe.
Affiliation
  • Ehrlich M; Novartis Pharma GmbH, Nuremberg, Germany.
  • Hentschke C; Novartis Pharma GmbH, Nuremberg, Germany.
  • Sieder C; Novartis Pharma GmbH, Nuremberg, Germany.
  • Maier-Peuschel M; Novartis Pharma GmbH, Nuremberg, Germany.
  • Reuter U; Department of Neurology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. uwe.reuter@charite.de.
J Headache Pain ; 23(1): 141, 2022 Nov 15.
Article in En | MEDLINE | ID: mdl-36380284
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Migraine Disorders Type of study: Clinical_trials Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Migraine Disorders Type of study: Clinical_trials Limits: Humans Language: En Year: 2022 Type: Article